Literature DB >> 1487621

The effects of paroxetine, alone and in combination with alcohol on psychomotor performance and cognitive function in the elderly.

J S Kerr1, D B Fairweather, R Mahendran, I Hindmarch.   

Abstract

Fifteen healthy male volunteers aged over 60 years received acute and repeated doses of paroxetine 20 mg or placebo, and acute doses of lorazepam 1 mg (as a positive internal control) with or without alcohol (0.6 g/kg of body weight) administered openly in a double blind balanced crossover study in which each subject acted as his own control. Psychomotor performance and cognitive function were assessed using a test battery which included critical flicker fusion, choice reaction time, compensatory tracking, Stroop and memory scanning tests. Subjective ratings of mood and sleep were recorded using line analogue rating scales. The pattern of results indicated that paroxetine had little or no effect on most of the test variables, and in some instances (critical flicker fusion thresholds) improved information processing ability. This was in marked contrast to the lorazepam verum which produced sedation and disruption of performance. Paroxetine had a slight antagonistic effect on alcohol induced sedation whereas impairment of performance with lorazepam was potentiated by co-administration of alcohol. The low behavioural toxicity of paroxetine in elderly volunteers has important implications for the pharmacotherapy of depression.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1487621

Source DB:  PubMed          Journal:  Int Clin Psychopharmacol        ISSN: 0268-1315            Impact factor:   1.659


  7 in total

Review 1.  Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.

Authors:  N S Gunasekara; S Noble; P Benfield
Journal:  Drugs       Date:  1998-01       Impact factor: 9.546

Review 2.  Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Authors:  G J H Dumont; S J de Visser; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

Review 3.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

Review 4.  Pharmacokinetic interactions between alcohol and other drugs.

Authors:  A G Fraser
Journal:  Clin Pharmacokinet       Date:  1997-08       Impact factor: 6.447

Review 5.  Paroxetine. A review of its pharmacology, therapeutic use in depression and therapeutic potential in diabetic neuropathy.

Authors:  S M Holliday; G L Plosker
Journal:  Drugs Aging       Date:  1993 May-Jun       Impact factor: 3.923

6.  Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.

Authors:  R H Foster; K L Goa
Journal:  CNS Drugs       Date:  1997-08       Impact factor: 5.749

7.  The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review.

Authors:  Julie Em Schulkens; Kay Deckers; Maud Jenniskens; Arjan Blokland; Frans Rj Verhey; Sjacko Sobczak
Journal:  J Psychopharmacol       Date:  2022-04-29       Impact factor: 4.562

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.